Lysine Methyltransferase SMYD2 Enhances Androgen Receptor Signaling To Modulate CRPC Cell Resistance to Enzalutamide

SMYD2 knockdown dramatically inhibited the proliferation, migration, invasion, and epithelial-mesenchymal transition potential of 22Rv1 and C4-2 cells.